the authors reported a significant reduction in all-cause mortality (p=0.009) in the group of transplant recipients receiving steroids, treated with GLP-1 RAs, indicating a 38% lower risk of death compared to nonusers (55)
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, administered as a once-weekly subcutaneous injection
Key Background Eli Lilly, which makes the FDA-approved injectable weight loss treatment Zepbound, overtook Tesla in market value earlier this year
[7] Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, et al
doi: 10.1016/j.bbacli.2016.05.006 26 SaundersJ
Cytochrome P450 2D6 (Cyp2D6) Substrates Theoretically, phellodendron might increase serum levels of drugs metabolized by CYP2D6